Elekta AB Class B
EKTA B: XSTO (SWE)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
SEK 556.00 | Gryvq | Stzbqrn |
Elekta's Order Growth Still Choppy, but Long-Term Outlook Remains Attractive
Business Strategy and Outlook
Demand for radiotherapy should stay healthy over the next decade. Elekta stands to benefit, but its success depends on the continuing adoption of Unity as well as its ability to withstand competition from Siemens Healthineers.